Patent · US Active

Compositions and methods of enhancing immune responses

US9226957B2 · kind B2 · utility

16Cited by
24References
24Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 9, 2013
Grant dateJan 5, 2016
Priority date
Expiry dateDec 9, 2033

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are Salmonella enteritidis 13A strains and compositions comprising these strains. Also provided are methods of enhancing an immune response against Influenza A and methods of reducing morbidity associated with an Influenza A infection. Methods of enhancing an immune response to a vaccine vector by expressing a polypeptide of CD154 capable of binding CD40 are also disclosed. Methods of developing a bacterial vaccine vector are disclosed. Methods of generating scarless site-specific mutations in a bacterium are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.